Description
What is tirzepatide?
Tirzepatide is a 39-amino-acid dual agonist engineered from the GIP backbone with GLP-1 receptor activity added — the first “twincretin” to reach global prominence. It remains the reference compound for dual-incretin research, and searches for tirzepatide in Canada dwarf almost every other peptide.
Tirzepatide’s signature is synergistic incretin signalling: glucose-dependent insulin secretion, gastric-emptying dynamics, adipose GIP receptor activity, and downstream body-composition effects. Its long C20 fatty-diacid moiety gives it the extended stability profile that makes once-weekly dosing practical.
| Contents | 10 × 10mg vials of tirzepatide |
|---|---|
| Form | Lyophilized powder, sterile sealed vial |
| Purity | ≥99% (HPLC verified) |
| Batch | All 10 vials from one production lot |
| Certificate | Third-party COA per batch (request with your batch number) |
| Storage | Sealed: refrigerate 2–8°C; reconstituted: refrigerate and use within recommended timelines |
Handling
Lyophilized tirzepatide is robust in transit; once reconstituted with bacteriostatic water it should be refrigerated and handled with standard sterile technique.
Why buy tirzepatide as a 10-pack
Single-vial retail pricing punishes people who actually use volume. Our 10-pack format works out to $42.00 per vial — up to 30% below typical single-vial retail in Canada — and because every vial ships from one production lot, a single certificate of analysis covers your entire supply. One order, one batch, zero between-vial variance.
Quality & testing
Every lot is independently tested for identity (mass spectrometry) and purity (HPLC) before release. Packs ship cold-packed with tracking from our Canadian facility, and each order automatically includes one free vial of bacteriostatic water.
Reviews
There are no reviews yet.